Trinity Biotech (TRIB) Income from Continuing Operations (2009 - 2024)
Trinity Biotech recorded quarterly Income from Continuing Operations of 15797000.0 in Q4 2024, down 229.52% quarter-over-quarter from 4794000.0 in Q3 2024, and down 193.08% year-over-year from 16971463.03 in Q1 2024.
Trinity Biotech's Income from Continuing Operations history runs 16 years deep, the most recent figure standing at 15797000.0 for Q4 2024.
- In Q4 2024, Income from Continuing Operations fell 193.08% year-over-year to 15797000.0; the TTM figure through Dec 2024 stood at 30665000.0 (up 16.84% YoY), while the FY2025 annual figure was 37376000.0, down 19.73% from the prior year.
- Income from Continuing Operations came in at 15797000.0 for Q4 2024 at Trinity Biotech, down from 4794000.0 in the prior quarter.
- In the past five years, Income from Continuing Operations ranged from a high of 10687000.0 in Q3 2020 to a low of 18880000.0 in Q2 2023.
- A 5-year average of 4103550.0 and a median of 5092000.0 in 2023 frame the typical range for Income from Continuing Operations.
- Across the five-year window, Income from Continuing Operations soared 511.27% in 2020 and tumbled 2026.0% in 2022, its largest moves.
- Trinity Biotech's Income from Continuing Operations stood at 10361000.0 in 2020, then tumbled by 132.48% to 3365000.0 in 2021, then plunged by 210.31% to 10442000.0 in 2022, then soared by 48.38% to 5390000.0 in 2023, then tumbled by 193.08% to 15797000.0 in 2024.
- According to Business Quant data, Income from Continuing Operations over the past three periods registered 15797000.0, 4794000.0, and 6891000.0 for Q4 2024, Q3 2024, and Q2 2024 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 1.08 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 745.00 Mn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 1.15 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 1.34 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 380.70 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 273.95 Mn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 199.50 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 411.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 220.30 Mn |
| 10 | Trinity Biotech | 28,000.00 | -5.11 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -15.80 Mn |
| Sep 30, 2024 | -4.79 Mn |
| Jun 30, 2024 | -6.89 Mn |
| Mar 31, 2024 | -3.18 Mn |
| Dec 31, 2023 | -5.39 Mn |
| Sep 30, 2023 | -6.28 Mn |
| Jun 30, 2023 | -18.88 Mn |
| Mar 31, 2023 | -6.33 Mn |
| Dec 31, 2022 | -10.44 Mn |
| Sep 30, 2022 | -9.98 Mn |
| Jun 30, 2022 | -10.15 Mn |
| Mar 31, 2022 | -13.22 Mn |
| Dec 31, 2021 | -3.37 Mn |
| Sep 30, 2021 | 1.85 Mn |
| Jun 30, 2021 | 527,000.00 |
| Mar 31, 2021 | 4.39 Mn |
| Dec 31, 2020 | 10.36 Mn |
| Sep 30, 2020 | 10.69 Mn |
| Jun 30, 2020 | 1.75 Mn |
| Mar 31, 2020 | 3.05 Mn |
| Dec 31, 2019 | 1.70 Mn |
| Sep 30, 2019 | 2.67 Mn |
| Jun 30, 2019 | 8.10 Mn |
| Mar 31, 2019 | 2.67 Mn |
| Dec 31, 2018 | 3.20 Mn |
| Sep 30, 2018 | 2.37 Mn |
| Jun 30, 2018 | 3.04 Mn |
| Mar 31, 2018 | 3.10 Mn |
| Dec 31, 2017 | 958,000.00 |
| Sep 30, 2017 | 2.75 Mn |
| Jun 30, 2017 | 3.18 Mn |
| Mar 31, 2017 | 2.58 Mn |
| Dec 31, 2016 | -43.26 Mn |
| Sep 30, 2016 | -221,000.00 |
| Jun 30, 2016 | 2.37 Mn |
| Mar 31, 2016 | -983,000.00 |
| Dec 31, 2015 | 3.27 Mn |
| Sep 30, 2015 | 12.94 Mn |
| Jun 30, 2015 | 3.13 Mn |
| Mar 31, 2015 | 4.62 Mn |
| Dec 31, 2014 | 4.50 Mn |
| Sep 30, 2014 | 4.91 Mn |
| Jun 30, 2014 | 4.87 Mn |
| Mar 31, 2014 | 4.64 Mn |
| Dec 31, 2013 | 5.30 Mn |
| Sep 30, 2013 | 5.50 Mn |
| Jun 30, 2013 | 4.38 Mn |
| Mar 31, 2013 | 4.52 Mn |
| Dec 31, 2012 | 5.32 Mn |
| Sep 30, 2012 | 5.38 Mn |
| Jun 30, 2012 | 5.43 Mn |
| Mar 31, 2012 | 5.24 Mn |
| Dec 31, 2011 | 5.36 Mn |
| Sep 30, 2011 | 5.36 Mn |
| Jun 30, 2011 | 5.17 Mn |
| Mar 31, 2011 | 4.92 Mn |
| Dec 31, 2010 | 4.07 Mn |
| Sep 30, 2010 | 3.13 Mn |
| Jun 30, 2010 | 50.72 Mn |
| Mar 31, 2010 | 3.73 Mn |
| Dec 31, 2009 | 3.61 Mn |
| Sep 30, 2009 | 3.83 Mn |
| Jun 30, 2009 | 3.98 Mn |
| Mar 31, 2009 | 3.00 Mn |